News | 31/07/2026

July 2026: Munich Center for Cell and Gene Therapy founded

The MCCG leadership team (from left to right): Prof. Dr. rer. nat. Stylianos Michalakis, Deputy Director, Univ.-Prof. Dr. med. Marion Subklewe, Director of the MCCG,  Prof. Dr. med. Sebastian Kobold, Coordinator, and Univ.-Prof. Dr. med. Andreas Humpe, Quality Management Officer

The Munich Center for Cell and Gene Therapy has been established at LMU Medical Center. It was founded by five institutions: the Department of Medicine III, the Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, the Department of Clinical Pharmacology, the Department of Pediatrics, Dr. von Hauner Children’s Hospital, and the Department of Ophthalmology. At the inaugural meeting, Prof. Dr. Marion Subklewe was elected director. The deputy director is Prof. Dr. Stylianos Michalakis; the coordinator is Prof. Dr. Sebastian Kobold; and the quality management officer is Prof. Dr. Andreas Humpe. The center is intended to provide patients with structured, safe, and rapid access to cell and gene therapies.

Originally translated with DeepL